Search Results
Ongoing trials investigating the efficacy of pirtobrutinib in CLL
The promise of pirtobrutinib in the treatment of CLL
Pirtobrutinib resistance in CLL: early findings
Insights into the BRUIN CLL-322 trial
BRUIN CLL-322 update: fixed-duration pirtobrutinib plus VR vs VR in patients with R/R CLL
Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens
Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL
Updates from the Phase I/II BRUIN study: pirtobrutinib in CLL
Updates on non-covalent BTK inhibitors and their place in CLL treatment
Pirtobrutinib: The next generation of BTK inhibitors
BELLWAVE-001: nemtabrutinib in patients with R/R CLL/SLL
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL
